Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors: Illustrative real-world cases to support shared decision-making.

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)

Despite the paucity of data in infants with SHA the potential role of emicizumab prophylaxis should be discussed with families when clinically relevant, with decisions tailored to individual need.

Keyphrases

early onset
big data
smoking cessation
machine learning
human health
drug induced
climate change
data analysis